Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 17, 04 December 2023
Open
Access | Article
The mechanism of lapatinib and its application in breast cancer
* Author to whom correspondence should be addressed.
Abstract
This paper aims to study the synthetic route, mechanism of action and application of lapatinib in breast cancer. As a common malignant tumor, breast cancer poses a serious threat to the life and health of patients. As an effective targeted drug, lapatinib is significant in treating breast cancer. Its pharmacological effects can block the growth and metastasis of tumor cells by inhibiting specific signaling pathways and affect cancer cells’ metabolism and drug efficacy. Its molecular mechanism is mainly through targeting the epidermal growth factor receptor (EGFR) to inhibit the proliferation and survival of tumor cells. Studies on lapatinib’s drug metabolism and pharmacodynamics also described its metabolism and therapeutic effect in vivo. Secondly, the pathophysiology of breast cancer was summarized, including the pathogenesis, clinical manifestations, and molecular biological characteristics of breast cancer. The therapeutic effect, application, efficacy evaluation, and adverse reaction management of lapatinib were analyzed for the application of lapatinib in the treatment of breast cancer. Moreover, the existing lapatinib synthetic routes were described. Lapatinib has a substantial treatment influence and may effectively decrease harmful reactions when used to treat breast cancer. Nevertheless, additional study is required to ascertain its optimal application and possible mechanism of action in breast cancer treatment.
Keywords
Lapatinib, Breast Cancer, Mechanism of Action
References
1. Alwan N A S 2016 J. Glob. Oncol. 2(5) 255
2. Anjum R and Blenis J 2008 Nat. Rev. Mol. Cell Biol. 9 747
3. Lara R, Seckl M J and Pardo O E 2013 Cancer Res. 73 5301
4. Romeo Y and Roux P P 2011 Expert Opin. Ther. Targets 15 5
5. Zheng B, Jeong J H, Asara J M, Yuan Y Y, Granter S R, Chin L and Cantley L C 2009 Mol. Cell 33 237
6. Cho Y Y 2017 Arch. Pharm. Res. 40 291
7. David J P, Mehic D, Bakiri L, Schilling A F, Priemel M, Idarraga M H, Reschke M O, Hoffmann O, Amling M and Wagner E F 2005 J. Clin. Invest. 115 664
8. Cho Y Y, He Z, Zhang Y, Choi H S, Zhu F, Choi B Y, Kang B S, Ma W Y, Bode A M and Dong Z 2005 Cancer Res. 65 3596
9. Li D, Jin L, Alesi G N, Kim Y M, Fan J, Seo J H, Wang D, Tucker M, Gu T L and Lee B H 2013 J. Biol. Chem. 288 32528
10. Lim H C, Xie L, Zhang W, Li R, Chen Z C, Wu G Z, Cui S S, Tan E K and Zeng L 2013 PLoS One 8 e74334
11. Cho Y Y, Yao K, Bode A M, Bergen H R, Madden B J, Oh S M, Ermakova S, Kang B S, Choi H S and Shim J H 2007 J. Biol. Chem. 282 8380
12. Shi X M 2022 Research on the mechanism of RSK2 promoting HER2 positive breast cancer cell proliferation and metastasis (Changsha: Central South University)
13. Zhang Q W, Zhou H Y and You Q D 2010 J. China Pharm. Univ. 41 317
14. Khabnadideh S, Pez D, Musso A, Brun R, Pérez L M R, González-Pacanowska D and Gilbert I H 2005 Bioorgan. Med. Chem. 13 2637
15. Wang J and Xu B 2019 Nature 4(1) 34
16. Wissner A, Fraser H L, Ingalls C L, Dushin R G, Floyd M B, Cheung K, Nittoli T, Ravi M R, Tan X and Loganzo F 2007 Bioorgan. Med. Chem. 15 3635
17. Fischer R W and Misun M 2001 Org. Proc. Res. Dev. 5 581
18. Mcclure M S, Osterhout M H, Roschangar F and Sacchetti M J 2007 Quinazoline ditosylate salt compounds (U.S. Patent No. 7,157,466)
19. Ji X, Wang W W, Xu G H, Li F and Yao S C 2009 Chin. J. Pharm. Industry 40 801
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-197-1
- ISBN (Online)
- 978-1-83558-198-8
- Published Date
- 04 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/17/20240626
- Copyright
- 04 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited